Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • News
  • Industry
  • Pharma News
  • With Rs 3,788 Crore in...

With Rs 3,788 Crore in Savings, Govt Eyes Adding More Drugs Under NLEM

Farhat NasimWritten by Farhat Nasim Published On 2025-03-24T17:40:12+05:30  |  Updated On 24 March 2025 5:40 PM IST
Department of Pharma invites fresh applications under PLI scheme for bulk drugs
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

"The arbitrary exclusion of essential medicines from price control must be addressed immediately," the Govt Panel said.

New Delhi: Observing that failure to regulate essential medicines allows pharmaceutical companies to impose arbitrary pricing, the government is moving towards expanding the National List of Essential Medicines (NLEM) and strengthening drug price regulations, as highlighted in the Parliamentary Standing Committee on Chemicals and Fertilizers' eighth report on the Demands for Grants for 2025-26.

The committee has recommended urgent action to curb exorbitant drug prices and include more essential medicines under price control to ensure affordability for the public.

Price Regulation and the Impact on Essential Medicines

The report highlights concerns over the unchecked rise in prices of medicines outside the NLEM framework, stating:

"The Committee expresses serious concern over the unchecked rise in prices of medicines that do not fall under the purview of the National List of Essential Medicines (NLEM). While price regulation under the NLEM ensures affordability for essential medicines, a significant number of life-saving and widely prescribed drugs remain outside this regulatory framework, leading to exorbitant pricing. This creates an undue financial burden on the common people, making critical healthcare unaffordable, particularly for lower-income households."

In response to the committee’s inquiry regarding pricing criteria, the Department of Pharmaceuticals clarified that drug prices in India are regulated under the National Pharmaceutical Pricing Policy (NPPP), 2012 and Drugs (Prices Control) Order (DPCO), 2013. It further explained:

"Prices of scheduled medicines notified as Schedule-I of the DPCO, 2013 by the Department of Pharmaceuticals. The National List of Essential Medicines (NLEM) published by the Ministry of Health and Family Welfare is incorporated as the Schedule-I of the DPCO. Presently, NLEM, 2022 is notified as Schedule-I of DPCO,2013 vide notification dated 11.11.2022."

The report also details the impact of price fixation and refixation under NLEM 2022, stating:

"Fixation and refixation of prices under NLEM, 2022 has led to an average reduction of about 16.89% in prices, resulting in estimated annual savings of about Rs 3,788 crore to patients."

Recommendation to Expand NLEM & Cover More Drugs

The parliamentary committee has strongly recommended that the Department of Pharmaceuticals, NPPA, and CDSCO work together to expand the NLEM to include more essential and widely used medicines, particularly those required for chronic diseases, rare disorders, and critical care. The report emphasizes:

"The Committee strongly recommends that the Department of Pharmaceuticals, in coordination with the Central Drugs Standard Control Organization (CDSCO) and the National Pharmaceutical Pricing Authority (NPPA), take immediate steps to expand the scope of the NLEM to include more essential and widely used medicines, particularly those required for chronic diseases, rare disorders, and critical care. The failure to regulate these medicines allows pharmaceutical companies to impose arbitrary pricing, making essential treatments unaffordable for vast sections of the population."

Additionally, the committee called for a regular review of the NLEM, stating:

"The Committee further urges the Department to undertake a comprehensive review of the NLEM at regular intervals and ensure that the list reflects the evolving healthcare needs of the country. The arbitrary exclusion of essential medicines from price control must be addressed immediately. Any delay in expanding the NLEM would result in continued financial hardship for patients and compromise access to life-saving treatments."

928 Scheduled Formulations Under Price Control

The report also provides insights into the existing scope of price regulation, revealing that as of March 6, 2025, ceiling prices have been set for 928 scheduled formulations across multiple therapeutic categories, including 131 anti-cancer drugs, 11 anti-diabetic medications, 65 cardiovascular drugs, 1 haemodialysis solution, 10 diuretics formulations

It states;

"As on 6.3.2025, ceiling prices of 928 scheduled formulations across various therapeutic categories were in effect. These include 131 anti-cancer, 11 anti-diabetic, 65 cardiovascular, 1 haemodialysis solution and 10 diuretics scheduled formulations."

Stricter Compliance & Industry Challenges

The report further elaborates on pricing obligations for pharma companies, highlighting the role of the National Pharmaceutical Pricing Authority (NPPA):

"NPPA fixes the ceiling prices of scheduled medicines, that is, the medicines specified in the said Schedule. The prices fixed by NPPA are applicable to all manufacturers/marketers selling the specified formulations, whether generic or branded. Manufacturers/marketers of scheduled medicines (branded or generic) are required to sell the same within the ceiling price fixed by the NPPA and applicable GST and annual revision on the basis of WPI."

For non-scheduled formulations, it adds:

"For non-scheduled formulations (branded or generic), the manufacturers may not increase the maximum retail price of such formulations by more than 10% per annum."

This means pharma companies must carefully navigate compliance requirements while maintaining sustainable business models in a highly regulated market.

nlem expansionscheduled medicinesessential medicinesdpco 2013price capchronic disease medicationrare disease treatmentnlemparliamentary panelnppacdscolatest pharma newscancerdiabetesdrug price controlcardiovascular
Farhat Nasim
Farhat Nasim

    Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

    Show Full Article
    Next Story

    Editorial

    National Consensus 2025 on Role of Bisoprolol Across CV Continuum in Women: Top 10 Takeaways

    National Consensus 2025 on Role of Bisoprolol Across CV Continuum in Women: Top 10 Takeaways

    Relevance of Pioglitazone in Indian T2DM Care Continuum

    Relevance of Pioglitazone in Indian T2DM Care Continuum

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

    First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

    Re-visiting the Role of Pneumococcal Vaccination in Patients with Cardiovascular Diseases

    Re-visiting the Role of Pneumococcal Vaccination in Patients with Cardiovascular Diseases

    View All

    Journal Club Today

    Study Reveals Why Your Immune System Works Better in Daylight

    Study Reveals Why Your Immune System Works Better in Daylight

    View All

    Health News Today

    Health Bulletin 29/May/2025

    Health Bulletin 29/May/2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok